Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Flexible Conductive Hearing Aids

NCT: NCT07222202 · RECRUITING

NCT IDNCT07222202
StatusRECRUITING
Start Date2026-01-14
Completion2027-11
SponsorWake Forest University Health Sciences (OTHER)
First posted
Last updated

Brief Summary

Conductive hearing loss (CHL) is the most common type of hearing loss among the pediatric population. CHL occurs when sound is not properly transmitted from the external ear to the cochlea, and congenital pathologies like microtia/anotia, atresia, and absent or malformed ossicles make hearing loss permanent.

Frequently Asked Questions

What is Evaluation of Flexible Conductive Hearing Aids?

Evaluation of Flexible Conductive Hearing Aids is a clinical trial registered under NCT07222202. Current status: RECRUITING.

What is the status of NCT07222202?

The current status of NCT07222202 (Evaluation of Flexible Conductive Hearing Aids) is: RECRUITING.

When did Evaluation of Flexible Conductive Hearing Aids start?

Evaluation of Flexible Conductive Hearing Aids started on 2026-01-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑